Abstract
Objectives: To investigate if supplementation of preterm infant formula with a high docosahexaenoic acid/eicosapentaenoic acid (DHA/EPA) ratio together with α-linolenic acid (ALA) was able to maintain plasma and red blood cell DHA levels similar to that obtained with breast milk feeding without altering n-6 fatty acid status.
Design and subjects: Preterm infants of mothers who elected not to breast feed (n=13) were assigned to ALA- and DHA-enriched formula (DHA group: DHA/EPA=5/l). Infants fed breast milk (n=25) constituted a reference group (BM group). Anthropometric and fatty acid parameters (plasma phospholipids, cholesterol esters, triglycerides and red blood cell phosphatidylethanolamine, PL, CE, TG, RBC-PE, respectively) were obtained after 2 days (D2) and 15 days (D15) of enteral feeding and at the 37th week (W37) of post-conception age and 1 month later (W37+30) in the DHA group. Mean DHA intake ranged between 16.5±1.6 and 17.9±2.9 mg/kg/day between D2 and W37+30.
Results: At W37, infant weights, heights, and head circumferences were similar in DHA and BM groups. PL DHA was maintained in the DHA group at the same level as in the BM group and the same for DHA in PE at W37. In RBC-PE and at W37, AA status was the same in both groups. In PL, AA levels remained very stable throughout the study; however, in the DHA group AA levels in PL remained in the range observed with standard formulas.
Conclusion: The combined 18:3 n-3 and DHA supplementation of infant formula with DHA/EPA ratio 5/l is compatible with growth and n-3 fatty acid metabolism similar to that of preterm infants fed human milk.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Babin F, Rodriguez A, Vandeputte B, Mendy F & Descomps B (2000): Alpha linolenic acid in cholesterol esters: a marker of alphalinolenic acid intake in newborns. Eur. J. Clin. Nutr. 54, 840–843.
Balcao WH, Kemppinen A, Malcata FX & Kalo PJ (1998): Modification of butterfat by selective hydrolysis and esterification by lipase: process and product characterization. J. Am. Oil Chem. Soc. 75, 1347–1358.
Billeaud C, Bougle D, Sarda P, Combe N, Mazette S, Babin F, Entressangles B, Descomps B, Nouvelot A & Mendy F (1997): Effects of preterm infant formula supplementation with α-linolenic acid with a linoleate/α-linolenate ratio of 6/1: a multicentric study. Eur. J. Clin. Nutr. 51, 520–526.
Birch EE, Birch DG, Hoffman DR & Uauy R (1992): Dietary essential fatty acid supply and visual acuity development. Invest. Opthalmol. Vis. Sci. 33, 3242–3253.
Birch EE, Garfield S, Hoffman DR, Uauy R & Birch DG (2000): A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev. Med. Child. Neurol. 42, 174–181.
Bourre JM, François M, Youyou A, Dumont O, Piciotti M & Pascal G (1989): The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J. Nutr. 119, 1880–1892.
Carlson SE, Cooke PJ, Werkman SH & Tolley EA (1992): First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula. Lipids 27, 901–907.
Carlson SE, Werkman SH, Rhodes PG & Tolley EA (1993): Visual acuity development in healthy preterm infants: effect of marine oil supplementation. Am. J. Clin. Nutr. 58, 35–42.
Carnielli VP, Pederzini F, Vittorangeli R, Lujendjik IHT, Pedrotti D & Sauer PJJ (1996): Plasma and red blood cell fatty acid of very low birth weight infants fed exclusively with expressed preterm human milk. Pediatr. Res. 39, 671–679.
Clandinin MT, Chappell JE, Heim T, Swyer PR & Chance GW (1981): Fatty acids utilization in perinatal de novo synthesis of tissues. Early Hum. Dev. 5, 355–366.
Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR & Chance GW (1980): Intrauterine fatty acid accretion rates in human brain: implication for fatty acid requirements. Early Hum. Dev. 4, 121–129.
Clandinin MT, Van Aerde JE, Parrott A, Field CJ, Euler AR & Lien E (1999): Assessment of feeding different amounts of arachidonic and docosahexaenoic acids in pretetrm infant formulas on the fatty acid. Acta Paediatr. 88, 890–896.
Demmelmair H, Feldt F, Horwath I, Niederland T, Ruzinko V, Raederstorff D, De Min C, Muggli R & Kolezko B (2001): Influence of formulas with borage oil or borage oil plus fish oil on the arachidonic acid status in premature infants. Lipids 36, 555–566.
Folch J, Lees M & Sloane Stanley GH (1957): A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226, 497–509.
Gibson RA, Makrides M, Neumann MA, Simmer K, Mantzioris E & James MJ (1994): Ratios of linoleic acid to α-linoleic acid in formulas for term infants. J. Pediatr. 125, S48–S55.
Hornstra G (2000): Essential fatty acids in mothers and their neonates. Am. J. Clin. Nutr. 7, 1262S–1269S.
Lapillonne A, Picaud JC, Chirouze V, Goudable J, Reygrobellet B, Claris O & Salle BL (2000): The use of low-EPA fish oil for long-chain polyunsaturated fatty acid supplementation of preterm infants. Pediatr. Res. 48, 835–841.
Makrides M, Neumann MA, Byard RW, Simmer K & Gibson RA (1994): Fatty acid composition of brain retina, and erythrocytes in breast- and formula-fed infants. Am. J.Clin. Nutr. 60, 189–194.
Martinez M (1992): Tissue levels of polyunsaturated fatty acids during early human development. J. Pediatr. 120, S129–S138.
Rapoport SI, Chang MC & Spector AA (2001): Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J. Lipid. Res. 42, 678–685.
Reisbick S, Neuringer M & Connor WE (1996): Effects of n-3 fatty acid deficiency in non human primates. In Recent Developments in Infant Nutrition, eds JO Bindels, AC Goedhart & HKA Visser, Dordrecht: Kluwer. pp 157–172.
Rietsh J (1982): Etude de la structure glycéridique de la nouvelle huile de Colza. Rev. Frs. Corps Gras. 29, 75–77.
Rodriguez A, Sarda P, Nessmann C, Boulot P, Leger CL & Descomps B (1998a): Δ6- and Δ5-desaturase activity in human foetal liver: kinetic aspects. J. Lipid Res. 39, 1825–1832.
Rodriguez A, Sarda P, Nessmann C, Boulot P, Poisson JP, Leger CL & Descomps B (1998b): Fatty acid desaturase activities and long chain polyunsaturated fatty acid composition in human liver between the 17th and 36th gestation week. Am. J. Obstet. Gynecol. 179, 1063–1070.
Salem N, Wegher B, Mena P & Uauy R (1996): Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc. Natl Acad. Sci. 93, 49–54.
Uauy RD, Birch DG, Birch EE, Tysion JE & Hoffman DR (1990): Effect of dietary omega 3 fatty acids on retinal function of very-low birth-weight neonates. Pediatr. Res. 8, 485–492.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rodriguez, A., Raederstorff, D., Sarda, P. et al. Preterm infant formula supplementation with α linolenic acid and docosahexaenoic acid. Eur J Clin Nutr 57, 727–734 (2003). https://doi.org/10.1038/sj.ejcn.1601604
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1601604